Worldquant Millennium Advisors LLC Raises Position in Colgate-Palmolive (NYSE:CL)

Worldquant Millennium Advisors LLC raised its stake in shares of Colgate-Palmolive (NYSE:CL) by 19.4% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 142,881 shares of the company’s stock after purchasing an additional 23,232 shares during the period. Worldquant Millennium Advisors LLC’s holdings in Colgate-Palmolive were worth $10,240,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently modified their holdings of the company. Parsec Financial Management Inc. grew its position in shares of Colgate-Palmolive by 0.5% during the 2nd quarter. Parsec Financial Management Inc. now owns 30,081 shares of the company’s stock valued at $2,156,000 after acquiring an additional 146 shares during the period. Heritage Way Advisors LLC grew its position in shares of Colgate-Palmolive by 0.4% during the 2nd quarter. Heritage Way Advisors LLC now owns 33,769 shares of the company’s stock valued at $2,420,000 after acquiring an additional 146 shares during the period. Tiemann Investment Advisors LLC grew its position in shares of Colgate-Palmolive by 2.4% during the 1st quarter. Tiemann Investment Advisors LLC now owns 6,455 shares of the company’s stock valued at $442,000 after acquiring an additional 150 shares during the period. Moloney Securities Asset Management LLC grew its position in shares of Colgate-Palmolive by 2.7% during the 2nd quarter. Moloney Securities Asset Management LLC now owns 6,038 shares of the company’s stock valued at $433,000 after acquiring an additional 157 shares during the period. Finally, Balasa Dinverno & Foltz LLC grew its position in shares of Colgate-Palmolive by 4.7% during the 1st quarter. Balasa Dinverno & Foltz LLC now owns 3,666 shares of the company’s stock valued at $251,000 after acquiring an additional 164 shares during the period. Institutional investors and hedge funds own 75.95% of the company’s stock.

CL stock traded down $0.25 during trading on Wednesday, hitting $72.24. The stock had a trading volume of 2,282,082 shares, compared to its average volume of 3,022,701. The company has a debt-to-equity ratio of 32.25, a current ratio of 1.13 and a quick ratio of 0.78. Colgate-Palmolive has a twelve month low of $57.41 and a twelve month high of $76.41. The stock has a market capitalization of $60.88 billion, a P/E ratio of 24.32, a PEG ratio of 4.57 and a beta of 0.75. The company’s 50-day moving average price is $72.23 and its two-hundred day moving average price is $71.12.



Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, July 26th. The company reported $0.72 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.72. Colgate-Palmolive had a net margin of 14.77% and a negative return on equity of 10,821.98%. The business had revenue of $3.87 billion for the quarter, compared to analyst estimates of $3.88 billion. During the same period last year, the company posted $0.77 EPS. The business’s revenue was down .5% on a year-over-year basis. As a group, sell-side analysts expect that Colgate-Palmolive will post 2.84 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Wednesday, October 23rd will be paid a $0.43 dividend. This represents a $1.72 dividend on an annualized basis and a yield of 2.38%. The ex-dividend date of this dividend is Tuesday, October 22nd. Colgate-Palmolive’s dividend payout ratio (DPR) is 57.91%.

In other Colgate-Palmolive news, VP Philip G. Shotts sold 8,919 shares of the firm’s stock in a transaction that occurred on Tuesday, August 13th. The shares were sold at an average price of $71.05, for a total value of $633,694.95. Following the transaction, the vice president now directly owns 50,399 shares of the company’s stock, valued at approximately $3,580,848.95. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Henning I. Jakobsen sold 858 shares of the firm’s stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $74.60, for a total transaction of $64,006.80. Following the completion of the transaction, the chief financial officer now directly owns 39,031 shares in the company, valued at $2,911,712.60. The disclosure for this sale can be found here. Insiders sold a total of 569,298 shares of company stock worth $40,914,565 over the last three months. Corporate insiders own 1.14% of the company’s stock.

CL has been the topic of several research analyst reports. Morgan Stanley lifted their price objective on Colgate-Palmolive from $72.00 to $74.00 and gave the stock an “equal weight” rating in a report on Monday, July 29th. Bank of America set a $80.00 price objective on Colgate-Palmolive and gave the stock a “buy” rating in a report on Friday, July 12th. ValuEngine cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Wells Fargo & Co lifted their price objective on Colgate-Palmolive from $68.00 to $70.00 and gave the stock a “market perform” rating in a report on Monday, July 29th. Finally, UBS Group lifted their price objective on Colgate-Palmolive from $80.00 to $82.00 and gave the stock a “buy” rating in a report on Monday, July 29th. One research analyst has rated the stock with a sell rating, eleven have issued a hold rating and six have issued a buy rating to the company. Colgate-Palmolive presently has an average rating of “Hold” and an average price target of $74.07.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Recommended Story: Market Capitalization

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.